Literature DB >> 10620125

Role of cytotoxic T cells in chronic alopecia areata.

C Bodemer1, M Peuchmaur, S Fraitaig, L Chatenoud, N Brousse, Y De Prost.   

Abstract

Cytokines play a role in alopecia areata. We used immunohistochemical and in situ hybridization studies to demonstrate the persistence of pro-inflammatory as well as apoptotic mechanisms in skin biopsies from patients with chronic alopecia areata. In situ hybridization allows the visualization of the distribution of immunocompetent cells in vivo. We studied skin biopsies from 11 untreated alopecia areata patients and two normal controls. In situ hybridization was performed on frozen sections using 35S-radio-labeled riboprobes, specific for IL-1beta, IL-2, IL-6, INFgamma, and granzyme B mRNA. Immunohistochemistry was carried out using an anti-IL-1beta monoclonal antibody, and a monoclonal antibody directed against the human Fas protein. We demonstrated the presence of cells labeled with IL-1beta, IL-6, INFgamma, and granzyme B antisense probes. Similarly, cells labeled with anti-IL-1beta were found in 10 of 11 cases. The labeled cells were located in the mononuclear peri- and intrafollicular infiltrate. Cells expressing granzyme B were found in close contact with the follicle. Fas positivity was demonstrated in four of four cases at the level of the cytoplasmic membrane of the hair follicle keratinocytes. These results, based on visualizing the labeled cells, demonstrate that pro-inflammatory cytokines are produced by the mononuclear cell infiltrate in close contact with follicles in alopecia areata. Furthermore, they demonstrate for the first time that apoptotic mechanisms involving granzyme B and Fas-Fas ligand pathways may play a major role in the persistence of chronic alopecia areata.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620125     DOI: 10.1046/j.1523-1747.2000.00828.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

2.  Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.

Authors:  Doreen Nazeih Assaad Younan; Naglaa Agamia; Adel Elshafei; Nancy Ebeid
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 3.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 4.  [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].

Authors:  P Freyschmidt-Paul; R Happle; R Hoffmann
Journal:  Hautarzt       Date:  2003-08       Impact factor: 0.751

Review 5.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 6.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

7.  Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Elizabeth Alvarez-Connelly; Jessica Simon; Lucia M Mauro; Javier Guzman; George Elgart; Lawrence A Schachner; Juan Chen; Lisa R Plano; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2010-06-27       Impact factor: 3.667

Review 8.  Cytokines and other mediators in alopecia areata.

Authors:  Stamatis Gregoriou; Dafni Papafragkaki; George Kontochristopoulos; Eustathios Rallis; Dimitrios Kalogeromitros; Dimitris Rigopoulos
Journal:  Mediators Inflamm       Date:  2010-03-11       Impact factor: 4.711

9.  Association between PTPN22 C1858T polymorphism and alopecia areata risk.

Authors:  Mauricio Salinas-Santander; Celia Sánchez-Domínguez; Cristina Cantú-Salinas; Hugo Gonzalez-Cárdenas; Ana Cecilia Cepeda-Nieto; Ricardo M Cerda-Flores; Rocío Ortiz-López; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2015-09-04       Impact factor: 2.447

10.  Sex-related differences in urinary immune-related metabolic profiling of alopecia areata patients.

Authors:  Yu Ra Lee; Haksoon Kim; Bark Lynn Lew; Woo Young Sim; Jeongae Lee; Han Bin Oh; Jongki Hong; Bong Chul Chung
Journal:  Metabolomics       Date:  2020-01-16       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.